Global to lead PEGylated Proteins Market in 2022
PEGylated Proteins Market, published by Market Data Forecast, the Global market is projected to reach USD 1.45 billion by 2022, at a CAGR of 10.5% from 2017 to 2022.
(EMAILWIRE.COM, November 17, 2017 ) When the bonds (covalent or non-covalent) of Poly Ethylene Glycol (PEG) polymer chains itself to a macrostructure which in this case is a protein it is termed as PEGylation market. They protect proteins against enzymatic dehydration along with raising the half-life of drugs and so their importance has considerably increased over the past few years.
Get a comprehensive overview of the PEGylated Proteins Market: http://www.marketdataforecast.com/market-reports/pegylated-proteins-market-3355/
PEGylated Proteins Market: Drivers & Restraints
Rising R&D investments particularly in pharmaceutical sector, growing incidence of diseases, and wide acceptance of protein based drugs in contrast to non-protein drugs, and larger half-lives are the primary drivers of market growth.
Accumulation of high molecular weight compounds in liver being very dangerous and unpredictable and unknown effects of this procedure are the primary restraints of this market. Moreover, chain lengths of these compounds are easily alterable and therefore change often resulting in unexpected clearance times in vivo are the secondary factors restraining market growth.
Get accurate market forecast and analysis on the PEGylated Proteins Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/pegylated-proteins-market-3355/request-sample
PEGylated Proteins Market: Segmentation
By Protein Type
• Interferons
• Erythropoietin
• mAbs
By Consumables
• Reagents
• PEGylation Kits
By Application
• Chronic Kidney Diseases
• Cancer Treatment
By End-Users
• Pharmaceuticals & Biotechnology Companies
• CROs
• Academic Research Institutes
By Geography
• North America
o United States
o Canada
• Europe
o U.K
o Spain
o Germany
o Italy
o France
• Asia-Pacific
o China
o India
o Japan
o Australia
o South Korea
• Latin America
o Brazil
o Argentina
o Mexico
o Rest of Latin America
• Middle East & Africa
o Middle-East
o Africa
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization.
Get customization at http://www.marketdataforecast.com/market-reports/pegylated-proteins-market-3355/customize-report
PEGylated Proteins Market: Overview
In 2016, by end users Pharma and biotechnology was the market leader and is expected to remain so at the end of the aforementioned forecast period.
North America captures the largest market share of nearly 30% and is expected to remain so in the aforementioned forecast period. Asia Pacific is the fastest growing market and is likely to keep growing with this rate till the end of 2022. Latin America has huge potential and is likely to grow robustly in the aforementioned forecast period.
PEGylated Proteins Market: Key Players
Laysan Bio, Ltd., Iris Biotech GmbH, Biomatrik Inc., Quanta BioDesign Ltd., Cealares GmbH are the major players in the market. Other players in the market include Creative PEGworks, Jenkem Technology USA Inc., NOF Corporation, Thermo Fisher Scientific Inc., and Merck Millipore.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com
Get a comprehensive overview of the PEGylated Proteins Market: http://www.marketdataforecast.com/market-reports/pegylated-proteins-market-3355/
PEGylated Proteins Market: Drivers & Restraints
Rising R&D investments particularly in pharmaceutical sector, growing incidence of diseases, and wide acceptance of protein based drugs in contrast to non-protein drugs, and larger half-lives are the primary drivers of market growth.
Accumulation of high molecular weight compounds in liver being very dangerous and unpredictable and unknown effects of this procedure are the primary restraints of this market. Moreover, chain lengths of these compounds are easily alterable and therefore change often resulting in unexpected clearance times in vivo are the secondary factors restraining market growth.
Get accurate market forecast and analysis on the PEGylated Proteins Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/pegylated-proteins-market-3355/request-sample
PEGylated Proteins Market: Segmentation
By Protein Type
• Interferons
• Erythropoietin
• mAbs
By Consumables
• Reagents
• PEGylation Kits
By Application
• Chronic Kidney Diseases
• Cancer Treatment
By End-Users
• Pharmaceuticals & Biotechnology Companies
• CROs
• Academic Research Institutes
By Geography
• North America
o United States
o Canada
• Europe
o U.K
o Spain
o Germany
o Italy
o France
• Asia-Pacific
o China
o India
o Japan
o Australia
o South Korea
• Latin America
o Brazil
o Argentina
o Mexico
o Rest of Latin America
• Middle East & Africa
o Middle-East
o Africa
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization.
Get customization at http://www.marketdataforecast.com/market-reports/pegylated-proteins-market-3355/customize-report
PEGylated Proteins Market: Overview
In 2016, by end users Pharma and biotechnology was the market leader and is expected to remain so at the end of the aforementioned forecast period.
North America captures the largest market share of nearly 30% and is expected to remain so in the aforementioned forecast period. Asia Pacific is the fastest growing market and is likely to keep growing with this rate till the end of 2022. Latin America has huge potential and is likely to grow robustly in the aforementioned forecast period.
PEGylated Proteins Market: Key Players
Laysan Bio, Ltd., Iris Biotech GmbH, Biomatrik Inc., Quanta BioDesign Ltd., Cealares GmbH are the major players in the market. Other players in the market include Creative PEGworks, Jenkem Technology USA Inc., NOF Corporation, Thermo Fisher Scientific Inc., and Merck Millipore.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results